36 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
Amphastar’s Generic Ganirelix Acetate Injection Scores FDA Approval
The FDA has approved Amphastar Pharmaceuticals Inc’s (NASDAQ:AMPH) Abbreviated New Drug Application for Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syringe. …
Wells Fargo Maintains Equal-Weight on Amphastar Pharmaceuticals, Raises Price Target to $32
Wells Fargo analyst Jacob Hughes maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $23 to $32.
Piper Sandler Maintains Overweight on Amphastar Pharmaceuticals, Raises Price Target to $35
Piper Sandler analyst David Amsellem maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Overweight and raises the price target from $28 to $35.
Amphastar Pharmaceuticals: Q4 Earnings Insights
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Preview For Amphastar Pharmaceuticals
Amphastar Pharmaceuticals (NASDAQ:AMPH) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.
Analysts estimate that Amphastar Pharmaceuticals will report an earnings per share (EPS) of $0.37.